Allena Pharmaceuticals Inc EV/EBIT
Was ist das EV/EBIT von Allena Pharmaceuticals Inc?
EV/EBIT von Allena Pharmaceuticals Inc ist N/A
Was ist die Definition von EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Allena Pharmaceuticals Inc
Unternehmen mit ev/ebit ähnlich Allena Pharmaceuticals Inc
- Hi Crush Inc hat EV/EBIT von N/A
- Cocrystal Pharma Inc hat EV/EBIT von N/A
- Panorama Capital hat EV/EBIT von N/A
- Nuverra Environmental Solutions Inc hat EV/EBIT von N/A
- Touchpoint hat EV/EBIT von N/A
- Equity Metals hat EV/EBIT von N/A
- Allena Pharmaceuticals Inc hat EV/EBIT von N/A
- Queen's Road Capital Investment hat EV/EBIT von N/A
- Uxin Ltd hat EV/EBIT von N/A
- Red Light Holland hat EV/EBIT von N/A
- St. James Gold hat EV/EBIT von N/A
- Eat Beyond Global hat EV/EBIT von N/A
- Consolidated Firstfund Capital hat EV/EBIT von N/A